The monoclonal antibody A103 to the melanocytic differentiation antigen Melan A stains human steroid-producing cells and their tumors. A total of 200 formalin-fixed, paraffin-embedded canine normal tissues and hyperplastic and neoplastic lesions of the adrenal gland, testis, and ovary were immunohistochemically tested for Melan A with antibody A103. Leydig cell tumors (23/23, 100%), Sertoli cell tumors (14/15, 93%), and adrenocortical adenomas (12/13, 92%) were consistently positive. Adrenocortical carcinomas (23/35, 65%) and granulosa cell tumors (10/17, 59%) were less frequently positive. All pheochromocytomas, seminomas, and dysgerminomas were negative. The pattern of staining was cytoplasmic, but nuclear staining was also frequently seen in normal Leydig cells and their tumors. As in human tumors, immunohistochemistry for Melan A stains many canine steroid-producing tumors and can be used to distinguish these tumors from those of nonstereidogenic cells.
Health Diagnostic Laboratory databases were searched for biopsies and necropsies containing adrenal gland, ovarian, or testicular tumors. A total of 200 normal, hyperplastic, or neoplastic tissues, including testicular tumors (Leydig cell tumor, Sertoli cell tumor, and seminoma), ovarian tumors (granulosa-theca, luteoma, dysgerminoma, and carcinoma), and adrenal lesions (adrenal cortical hyperplasia, adrenocortical adenoma, adrenocortical carcinoma, and pheochromocytoma) corresponding to 182 canine accessions were selected for this study. Diagnoses were initially made by the case coordinator; every case was reviewed by another pathologist (JAR) using reported classification criteria. 2, 14, 15 If discrepancies in the diagnosis based on hematoxylin and eosin-stained sections were found, a consensus among 3 pathologists was reached. Tissues had been fixed for an undetermined period of time in neutral buffered formalin and routinely processed.
For immunohistochemistry, a previously reported protocol for Melan A detection in canine oral melanomas was followed. 17 Four-micrometer sections on positively charged slides were deparaffinized and hydrated. To detect Melan A, heat-induced epitope retrieval (HIER) was necessary, heating the slides in ethylenediaminetetraacetic acid buffer (pH 8.0) with a steamer for 20 min. A mouse monoclonal antibody (clone A103) a to Melan A was used at a concentration of 1.15 g/ml and incubated for 90 min at room temperature (RT). A 2-step, non-avidin-biotin method, ENVISIONϩ/ peroxidase, a was used as the signal-generating system. The chromagen was diaminobenzidine, and the slides were counterstained with Mayer hematoxylin. The entire immunohistochemical staining procedure except the HIER was done in an automatic immunostainer. a For selected adrenal tumors, immunohistochemistry for chromogranin A a and neuron-specific enolase a was performed using reported methods. 16 An unrelated monoclonal antibody of the same isotype and similar protein concentration replaced the primary monoclonal antibody for negative control. For polyclonal antibodies, normal rabbit serum replaced the primary antibody. A semiquantitative evaluation of the percentage of positive tumor cells was used; where 1 ϭ 5-10% of positive cells, 2 ϭ 11-50%, 3 ϭ 51-80%, and 4 ϭ Ͼ80%. Normal or neoplastic tissues were considered negative if Ͻ5% of cells were stained by the antibody. A subjective grading system was used to determine the intensity of the reaction for Melan A, where 0 ϭ no reaction, 1 ϭ weak reaction, 2 ϭ moderate reaction, and 3 ϭ intense reaction.
Results
Staining of normal tissues. The adrenal cortex had diffuse, finely granular cytoplasmic staining mainly in the zona fasciculata and reticularis but also in the zona glomerulosa. Nuclear staining in cortical cells and staining of medullary cells or adrenal stromal cells was not apparent. This pattern of staining was consistent in all samples of normal adrenal tissue. Interstitial (Leydig) cells of the testis were consistently positive for Melan A with diffuse, finely granular cytoplasmic staining and usually strong diffuse nuclear staining. Sertoli cells were less commonly positive and showed only cytoplasmic staining. The intensity of staining of Sertoli cells was weaker than that of Leydig cells. Germinal and stromal cells of the testis were not reactive for Melan A. Only 1 of 2 normal ovaries gave a positive reaction for Melan A, which was located in developing follicles (mainly granulosa cells but also in spindle cells identified as theca cells) and in interstitial cells. The staining in the ovary was cytoplasmic only.
Staining of abnormal tissues. Table 1 summarizes the immunohistochemical results for Melan A in different organs. The pattern of staining of hyperplastic or neoplastic lesions was similar to that seen in their normal counterparts, but the percentage of positive lesions, the number of positive cells, and the intensity of reaction was variable. All adrenal cortical hyperplastic lesions (2/2) and most of the adenomas (12/13) were positive for Melan A (Fig. 1) , whereas only 23/ 35 (65.7%) adrenocortical carcinomas were positive for Melan A. The staining in all adrenocortical lesions, especially in carcinomas, was heterogeneous, with some areas strongly positive and others not stained at all. Neoplastic cells were usually similarly or less intensely stained than normal cortical cells, although compression of normal tissue might have increased the intensity of staining on these cells. None of the pheochromocytomas (0/12) were positive for Melan A.
Leydig cell (23/23, 100%) and Sertoli cell (14/15, 93%) tumors were positive for Melan A. The staining in Leydig cell tumors was similar to that found in normal Leydig cells, i.e., diffuse and granular cytoplasmic staining with nuclear staining in a variable number of cells. However, 14/23 (61%) Leydig tumors did not have nuclear staining for Melan A even when adjacent normal Leydig cells had strong nuclear staining. Sertoli cell tumors had diffuse and variable cytoplasmic staining for Melan A; only 5/14 (36%) Sertoli tumors had occasional cells with nuclear staining. Seminomas were consistently negative for this marker (Fig. 2) .
Ovarian tumors yielded the weakest and most heterogeneous reaction for Melan A among all neoplasms positive for this marker. Only granulosa-theca tumors (10/17, 59%) and luteomas (1/2, 50%) had positive staining (Fig. 3) . Although some granulosa-theca tumors were strongly positive, the majority were weakly stained with the antibody for Melan A. Staining in granulosa-theca tumors was diffuse and granular cytoplasmic except in 3 tumors in which a reduced number of cells also had nuclear staining. The only positive luteoma had numerous cells with a strong cytoplasmic reaction.
Other markers tested. All phechromocytomas were tested for the presence of chromogranin A and neuronspecific enolase (Fig. 4) . Chromogranin A was strongly positive in 12/12 (100%) tumors, and neuron-specific enolase was positive in 11/12 (92%) tumors. Chromogranin A stained only normal and neoplastic medullary cells and did not stain cortical cells. How- ever, neuron-specific enolase usually stained both cortical and medullary cells. The staining was cytoplasmic and sometimes nuclear.
Control slides that contained tissue previously reported as negative for Melan A 17 and/or tissue sections in which the primary antibody had been substituted for nonimmune rabbit serum (for chromogranin A) or an unrelated monoclonal antibody (for Melan A and neuron-specific enolase) did not show staining.
Discussion
This is the first description of immunohistochemical detection of Melan A in canine steroid-producing tissues. Human tissues known to react with antibody A103 to Melan A include skin (melanocytes), pancreas (weak staining of some islet cells), testis (Leydig cells and occasional Sertoli cells), ovary (granulosa-theca cells and stromal cells), and adrenal gland (cortical cells). 11 In a previous study, antibody A103 only stained the ductular epithelium in the canine pancreas. 17 In the present study, antibody A103 reacted with adrenocortical cells, granulosa-theca cells of the ovary, and Leydig and Sertoli cells of the testis. Reactivity to A103 antibody was also present in the cytoplasm of interstitial cells of the ovary, which has not been reported in human tissues. 11 Overall, the staining pattern in adrenal, testicular, and ovarian neoplasms was similar to that described in human tumors. 5, 6, 11 However, the number of positive cases for a given type of tumor and the location of the staining was somewhat different. Only 65% of canine adrenocortical carcinomas were positive for Melan A. The majority of human adrenocortical tumors are positive for this marker. 5, 20 In 1 study, only 68% of human adrenocortical adenomas and 100% of adrenocortical carcinomas were positive for Melan A. 18 As in humans, 5, 6, 11 the canine granulosa cell tumors in this study gave the weakest and most inconsistent reaction for Melan A.
Nuclear staining was prominent in many Leydig tumors but was much less common in Sertoli and granulosa tumors. Nuclear staining with Melan A antibodies has not been reported in human steroid-producing tumors or in human or canine melanomas. 5, 6, 11, 17, 18, 20 This pattern of staining might indicate that the molecule recognized by Melan A antibody is different from that reported in human tumors. Alternatively, the expression of this cross-reacting antigen might differ among canine tumors. Antigen diffusion and redistribution after fixation could not be ruled out completely.
Chromogranin A and neuron-specific enolase are commonly used as markers of neuroendocrine differentiation. 7 Canine adrenal medullary cells and their tumors were consistently stained with antibodies to chromogranin A and neuron-specific enolase. Neuronspecific enolase but not chromogranin A also stained cortical cells. Therefore, chromogranin A could be used in conjunction with Melan A to distinguish cortical from medullary adrenal tumors and their metastases.
Antibody A103 to Melan A detects steroid-producing cells in canine testis, adrenal gland, and ovaries, and Melan A staining of canine steroid-producing tumors is qualitatively similar to that seen in human counterparts but is quantitatively different. Melan A is a good marker for adrenocortical tumors, and the combination of Melan A and chromogranin A allows the differentiation of adrenal neoplasms and their metastases.
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